ACCELERATED PHASE CHRONIC MYELOGENOUS LEUKEMIA
Clinical trials for ACCELERATED PHASE CHRONIC MYELOGENOUS LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new ACCELERATED PHASE CHRONIC MYELOGENOUS LEUKEMIA trials appear
Sign up with your email to follow new studies for ACCELERATED PHASE CHRONIC MYELOGENOUS LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Smarter CMV strategy may protect stem cell transplant patients from dangerous infection
Disease control OngoingThis study tested a modified approach to prevent and manage cytomegalovirus (CMV) infection in 153 people with blood cancers who had a donor stem cell transplant. The goal was to see if delaying or adjusting anti-CMV treatment could still keep patients safe while reducing unneces…
Matched conditions: ACCELERATED PHASE CHRONIC MYELOGENOUS LEUKEMIA
Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Apr 29, 2026 04:30 UTC
-
New hope for kids with rare leukemia: bosutinib trial launches
Disease control OngoingThis study tests a daily pill called bosutinib in children with Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML). It includes children who are newly diagnosed or whose cancer has stopped responding to other treatments. The goal is to find the best dose and see …
Matched conditions: ACCELERATED PHASE CHRONIC MYELOGENOUS LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated Apr 29, 2026 04:29 UTC